Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Clinical Trial

Rationale: Sensitization to Fel d 1 (Felis domesticus allergen 1) contributes to persistent allergic rhinitis and asthma. Existing treatment options for cat allergy, including allergen immunotherapy, are only moderately effective, and allergen immunotherapy has limited use because of safety concerns...

Descripción completa

Detalles Bibliográficos
Autores principales: Shamji, Mohamed H., Singh, Iesha, Layhadi, Janice A., Ito, Constance, Karamani, Angeliki, Kouser, Lubna, Sharif, Hanisah, Tang, Jiaqian, Handijiev, Sava, Parkin, Rebecca V., Durham, Stephen R., Kostic, Ana, Orengo, Jamie M., DeVeaux, Michelle, Kamal, Mohamed, Stahl, Neil, Yancopoulos, George D., Wang, Claire Q., Radin, Allen R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Thoracic Society 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437124/
https://www.ncbi.nlm.nih.gov/pubmed/33651675
http://dx.doi.org/10.1164/rccm.202011-4107OC

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437124/
https://www.ncbi.nlm.nih.gov/pubmed/33651675
http://dx.doi.org/10.1164/rccm.202011-4107OC

Ejemplares similares